IDYA: Ideaya Biosciences Inc Company Profile & Statistics

About

IDEAYA Biosciences Inc. is an oncology-focused precision medicine company. It focuses on the discovery and development of therapeutics for patients using molecular diagnostics. The company's product pipeline consists of IDE196, MAT2A, PARG, Pol-theta and WRN which are in clinical stage. IDEAYA Biosciences Inc. is based in South San Francisco, United States.

Info & Links

CEO

Yujiro Hata

Headquarters

7000 SHORELINE COURT, SUITE 350
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

124

Ideaya Biosciences Inc Statistics

Valuation Measures

Market Capitalization²

2.31B

Enterprise Value

1.91B

Enterprise Value/EBITDA(ttm)

-7.83

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

93.10

Price to Book(mrq)

1.80

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-216.38%

Return on Equity(ttm)

-19.42%

Return on Invested Capital(ttm)

-19.75%

Return on Assets(ttm)

-18.63%

Income Statement

Revenue(ttm)

3.92M

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

3.92M

EBITDA(ttm)³

-244.26M

Net Income Available to Common(ttm)

-178.12M

Diluted EPS(ttm)

-2.33

Share Statistics

Beta (5Y Monthly)

0.79

52-Week Change

-17.40%

S&P 500 52-Week Change

27.94%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

86.43M

Dividend Yield

0.00%

Float⁴

83.41M

% Held by Insiders

3.50%

% Held by Institutions

98.29%

Balance Sheet

Total Cash(mrq)

920.03M

Total Cash Per Share(mrq)

10.64

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

22.93%

Quick Ratio(mrq)

22.93%

Book Value Per Share(mrq)

13.67

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.46

Free Cash Flow(ytd)

-128.68M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IDYA

Ideaya Biosciences Inc

Ideaya Biosciences Inc Profile